United Capital Financial Advisors LLC Makes New Investment in Globe Life Inc. $GL

United Capital Financial Advisors LLC bought a new position in Globe Life Inc. (NYSE:GL) during the 2nd quarter, Holdings Channel reports. The fund bought 4,879 shares of the company’s stock, valued at approximately $872,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Globe Life by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after buying an additional 607 shares during the period. NewEdge Advisors LLC grew its stake in shares of Globe Life by 368.1% in the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock worth $897,000 after buying an additional 5,352 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Globe Life by 11.5% during the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after acquiring an additional 58,163 shares in the last quarter. Empowered Funds LLC purchased a new position in shares of Globe Life in the 1st quarter worth about $428,000. Finally, Focus Partners Wealth raised its position in shares of Globe Life by 8.3% in the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock worth $1,127,000 after purchasing an additional 656 shares during the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Trading Up 0.4%

Shares of GL opened at $173.41 on Monday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life Inc. has a 1 year low of $127.85 and a 1 year high of $191.55. The company has a 50 day simple moving average of $178.77 and a two-hundred day simple moving average of $159.66. The firm has a market cap of $13.33 billion, a P/E ratio of 11.51 and a beta of 0.48.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The company’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities analysts expect that Globe Life Inc. will post 15.71 earnings per share for the current fiscal year.

Globe Life declared that its Board of Directors has approved a share buyback plan on Monday, August 10th that allows the company to repurchase $2.50 billion in shares. This repurchase authorization allows the company to buy up to 17.7% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its shares are undervalued.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. Globe Life’s payout ratio is presently 8.76%.

Insider Buying and Selling at Globe Life

In related news, Director Cheryl Alston sold 8,258 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the completion of the transaction, the director directly owned 16,621 shares of the company’s stock, valued at approximately $2,979,148.04. This trade represents a 33.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Frank M. Svoboda sold 10,000 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the completion of the sale, the chief executive officer owned 54,020 shares in the company, valued at $9,004,053.60. This represents a 15.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 151,908 shares of company stock worth $27,239,981. Company insiders own 2.11% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on GL. Jefferies Financial Group increased their price objective on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research report on Friday, July 10th. Wells Fargo & Company lifted their price target on shares of Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. Piper Sandler upped their price objective on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. TD Cowen upped their target price on shares of Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Finally, Weiss Ratings downgraded Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $191.67.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.